The world press is discussing the prospects of the world’s first registered coronavirus vaccine. The British edition of The Spectator notes that Western countries are too wary of Russian development. The publication writes that the world community should understand and accept the fact that Moscow was ahead of the rest. As the author of the article emphasizes, if the vaccine really works – the whole world will benefit.
The head of the Israeli Medical Center Hadassah, who is involved in the development and testing of the vaccine, is also positively assessing the drug. The director general of the institution told reporters that Russian specialists have done a good job, Rossiya 24 TV channel reports.